Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | authKW | 812864 | 4% | 63% | 717 |
2 | ANGIOGENESIS | authKW | 793322 | 20% | 13% | 3448 |
3 | VEGF | authKW | 537035 | 9% | 19% | 1585 |
4 | ENDOSTATIN | authKW | 456675 | 2% | 62% | 408 |
5 | VASCULAR ENDOTHELIAL GROWTH FACTOR | authKW | 453864 | 8% | 19% | 1370 |
6 | VEGF C | authKW | 393363 | 2% | 67% | 330 |
7 | VASCULOGENIC MIMICRY | authKW | 306173 | 1% | 83% | 205 |
8 | ANGIOPOIETIN | authKW | 281393 | 2% | 52% | 305 |
9 | BEVACIZUMAB | authKW | 242758 | 4% | 18% | 755 |
10 | ANGIOPOIETIN 2 | authKW | 241897 | 1% | 63% | 213 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 95946 | 39% | 1% | 6835 |
2 | Pathology | 5832 | 6% | 0% | 1001 |
3 | Cell Biology | 5519 | 11% | 0% | 1920 |
4 | Medicine, Research & Experimental | 4700 | 7% | 0% | 1277 |
5 | Hematology | 3862 | 5% | 0% | 928 |
6 | Peripheral Vascular Diseases | 1847 | 4% | 0% | 659 |
7 | Biochemistry & Molecular Biology | 1529 | 12% | 0% | 2172 |
8 | Obstetrics & Gynecology | 827 | 3% | 0% | 509 |
9 | Developmental Biology | 692 | 2% | 0% | 287 |
10 | Pharmacology & Pharmacy | 658 | 6% | 0% | 1112 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL CANC BIOL | 155807 | 1% | 42% | 208 |
2 | TRANSLAT CANC BIOL PROGRAM | 50090 | 0% | 55% | 51 |
3 | WIHURI | 49430 | 0% | 56% | 49 |
4 | MICROVASC S | 32550 | 0% | 45% | 40 |
5 | EYE DIS DEV | 28161 | 0% | 60% | 26 |
6 | ANGIOGENESIS | 27307 | 1% | 16% | 97 |
7 | PROGRAM VIS SCI | 23278 | 0% | 50% | 26 |
8 | BIOMEDICUM HELSINKI | 22213 | 1% | 11% | 119 |
9 | MED ONCOL | 21719 | 5% | 2% | 798 |
10 | ENDOTHELIAL CELL BIOL UNIT | 20251 | 0% | 54% | 21 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANGIOGENESIS | 14270 | 0% | 17% | 47 |
2 | CLINICAL CANCER RESEARCH | 11634 | 2% | 2% | 322 |
3 | LYMPHOLOGY | 11261 | 0% | 8% | 83 |
4 | CANCER RESEARCH | 10088 | 3% | 1% | 488 |
5 | MICROVASCULAR RESEARCH | 9065 | 1% | 4% | 118 |
6 | BRITISH JOURNAL OF CANCER | 7209 | 2% | 2% | 279 |
7 | ANTICANCER RESEARCH | 6453 | 2% | 1% | 274 |
8 | LYMPHATIC RESEARCH AND BIOLOGY | 5617 | 0% | 12% | 26 |
9 | AMERICAN JOURNAL OF PATHOLOGY | 4142 | 1% | 1% | 178 |
10 | ONCOLOGY REPORTS | 3867 | 1% | 1% | 155 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | 812864 | 4% | 63% | 717 | Search LYMPHANGIOGENESIS | Search LYMPHANGIOGENESIS |
2 | ANGIOGENESIS | 793322 | 20% | 13% | 3448 | Search ANGIOGENESIS | Search ANGIOGENESIS |
3 | VEGF | 537035 | 9% | 19% | 1585 | Search VEGF | Search VEGF |
4 | ENDOSTATIN | 456675 | 2% | 62% | 408 | Search ENDOSTATIN | Search ENDOSTATIN |
5 | VASCULAR ENDOTHELIAL GROWTH FACTOR | 453864 | 8% | 19% | 1370 | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR |
6 | VEGF C | 393363 | 2% | 67% | 330 | Search VEGF+C | Search VEGF+C |
7 | VASCULOGENIC MIMICRY | 306173 | 1% | 83% | 205 | Search VASCULOGENIC+MIMICRY | Search VASCULOGENIC+MIMICRY |
8 | ANGIOPOIETIN | 281393 | 2% | 52% | 305 | Search ANGIOPOIETIN | Search ANGIOPOIETIN |
9 | BEVACIZUMAB | 242758 | 4% | 18% | 755 | Search BEVACIZUMAB | Search BEVACIZUMAB |
10 | ANGIOPOIETIN 2 | 241897 | 1% | 63% | 213 | Search ANGIOPOIETIN+2 | Search ANGIOPOIETIN+2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |